Vesicular monoamine transporter 2 mediates fear behavior in mice.

Vesicular monoamine transporter 2 mediates fear behavior in mice.
复制标题

DOI:
10.1111/gbb.12634
复制
发表时间:
2020-06
期刊:
Genes, brain, and behavior
影响因子:
--
通讯作者:
Miller GW
Miller GW
中科院分区:
其他
文献类型:
--
作者:
Branco RC;Burkett JP;Black CA;Winokur E;Ellsworth W;Dhamsania RK;Lohr KM;Schroeder JP;Weinshenker D;Jovanovic T;Miller GW

文献摘要

参考文献

被引文献

相似文献

经历过创伤事件的一部分人会出现创伤后应激障碍(PTSD),这与失调的恐惧行为有关。据报道,编码囊泡单胺转运蛋白 2 (VMAT2) 的基因 SLC18A2 的遗传变异会影响人类发生 PTSD 的风险。在这里,我们使用表达野生型 VMAT2 蛋白水平 5%(VMAT2-LO 小鼠)或 200%(VMAT2-HI 小鼠)的转基因小鼠。我们报告VMAT2-LO小鼠海马和杏仁核中的VMAT2蛋白减少,纹状体和额叶皮质中的单胺能囊泡储存能力受损,单胺代谢丰度降低,并且在刺激时释放多巴胺的能力大大降低。此外,VMAT2-LO小鼠表现出夸大的提示和情境恐惧表达、改变的恐惧习惯、无法区分威胁和安全提示、与野生型小鼠相比惊吓反应改变以及类似焦虑的表型,但没有表现出社交功能缺陷。相比之下,与野生型对照相比,VMAT2-HI 小鼠的整个大脑中的 VMAT2 蛋白增加,囊泡储存容量更高,刺激后多巴胺释放更多。在行为上,VMAT2-HI 小鼠在大多数检测中与野生型小鼠相似,有一些证据表明焦虑样反应减少。总之,这些数据表明,在我们的小鼠模型中,突触前单胺功能介导类似 PTSD 的结果,并表明 VMAT2 表达减少和恐惧行为之间存在因果关系,这与人类 VMAT2 基因型和 PTSD 风险之间的相关关系一致。针对这一系统是开发针对创伤后应激障碍(PTSD)等疾病的药物疗法的潜在策略。
A subset of people exposed to a traumatic event develop post-traumatic stress disorder (PTSD), which is associated with dysregulated fear behavior. Genetic variation in SLC18A2, the gene that encodes vesicular monoamine transporter 2 (VMAT2), has been reported to affect risk for the development of PTSD in humans. Here, we use transgenic mice that express either 5% (VMAT2-LO mice) or 200% (VMAT2-HI mice) of wild-type levels of VMAT2 protein. We report that VMAT2-LO mice have reduced VMAT2 protein in the hippocampus and amygdala, impaired monoaminergic vesicular storage capacity in both the striatum and frontal cortex, decreased monoamine metabolite abundance, and a greatly reduced capacity to release dopamine upon stimulation. Furthermore, VMAT2-LO mice showed exaggerated cued and contextual fear expression, altered fear habituation, inability to discriminate threat from safety cues, altered startle response compared to wild-type mice, and an anxiogenic-like phenotype, but displayed no deficits in social function. By contrast, VMAT2-HI mice exhibited increased VMAT2 protein throughout the brain, higher vesicular storage capacity, and greater dopamine release upon stimulation compared to wild-type controls. Behaviorally, VMAT2-HI mice were similar to wild-type mice in most assays, with some evidence of a reduced anxiety-like responses. Together, these data demonstrate that presynaptic monoamine function mediates PTSD-like outcomes in our mouse model, and suggest a causal link between reduced VMAT2 expression and fear behavior, consistent with the correlational relationship between VMAT2 genotype and PTSD risk in humans. Targeting this system is a potential strategy for the development of pharmacotherapies for disorders like PTSD.
DOI: 10.1016/j.psyneuen.2014.12.005
发表时间: 2015-03
影响因子: 3.7
作者:
Flandreau, Elizabeth;Risbrough, Victoria;Lu, Ailing;Ableitner, Martin;Geyer, Mark A.;Holsboer, Florian;Deussing, Jan M.
通讯作者: Deussing, Jan M.
DOI: 10.1016/j.neuropharm.2011.02.023
发表时间: 2012-02
期刊: Neuropharmacology
影响因子: 4.7
作者:
Jovanovic T;Kazama A;Bachevalier J;Davis M
通讯作者: Davis M
DOI: 10.1002/da.20880
发表时间: 2011-12-21
影响因子: 7.4
作者:
Glover, Ebony M.;Phifer, Justine E.;Crain, Daniel F.;Norrholm, Seth D.;Davis, Michael;Bradley, Bekh;Ressler, Kerry J.;Jovanovic, Tanja
通讯作者: Jovanovic, Tanja
DOI: 10.1111/j.1749-6632.2010.05906.x
发表时间: 2011-01
影响因子: 5.2
作者:
Eiden LE;Weihe E
通讯作者: Weihe E
DOI: 10.1001/archpsyc.1995.03950240066012
发表时间: 1995-12-01
影响因子: --
作者:
KESSLER, RC;SONNEGA, A;NELSON, CB
通讯作者: NELSON, CB